Syal Kirtimaan, Chakraborty Surajit, Bhattacharyya Rajasri, Banerjee Dibyajyoti
Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560 012, India; Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh 160 012, India.
Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh 160 012, India.
Med Hypotheses. 2015 Mar;84(3):199-203. doi: 10.1016/j.mehy.2014.12.022. Epub 2015 Jan 10.
Tuberculosis is continuing as a problem of mankind. With evolution, MDR and XDR forms of tuberculosis have emerged from drug sensitive strain. MDR and XDR strains are resistant to most of the antibiotics, making the management more difficult. BCG vaccine is not providing complete protection against tuberculosis. Therefore new infections are spreading at a tremendous rate. At the present moment there is experimental evidence to believe that Vitamin A and Vitamin D has anti-mycobacterial property. It is in this context, we have hypothesized a host based approach using the above vitamins that can cause possible prevention and cure of tuberculosis with minimal chance of resistance or toxicity.
结核病仍是困扰人类的一个问题。随着进化,耐多药和广泛耐药型结核病已从药物敏感菌株中出现。耐多药和广泛耐药菌株对大多数抗生素具有抗性,使得治疗更加困难。卡介苗不能提供完全的结核病防护。因此,新的感染正在以惊人的速度传播。目前有实验证据表明维生素A和维生素D具有抗分枝杆菌特性。正是在这种背景下,我们假设了一种基于宿主的方法,使用上述维生素,有望以最低的耐药或毒性风险预防和治愈结核病。